Bicuculline

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Bicuculline is a phthalide-isoquinoline compound that is a light-sensitive competitive antagonist of GABA A receptors. It was originally identified in 1932 in plant alkaloid extracts and has been isolated from Dicentra cucullaria, Adlumia fungosa, and several Corydalis species (all in subfamily Fumarioideae, previously known as family Fumariaceae).

Since it blocks the inhibitory action of GABA receptors, the action of bicuculline mimics epilepsy; it also causes convulsions. This property is utilized in laboratories around the world in the in vitro study of epilepsy, generally in hippocampal or cortical neurons in prepared brain slices from rodents.

This compound is also routinely used to isolate glutamatergic (excitatory amino acid) receptor function. The action of bicuculline is primarily on the ionotropic GABA A receptors, which are ligand-gated ion channels concerned chiefly with the passing of chloride ions across the cell membrane, thus promoting an inhibitory influence on the target neuron.

These receptors are the major targets for benzodiazepines, z-drugs, and related anxiolytic drugs. The half-maximal inhibitory concentration (IC 50 ) of bicuculline on GABA A receptors is 2 μM +/-0.1 at 40 μM of GABA (GABA half maximal effective concentration, (EC 50 )).…

Bicuculline is a phthalide-isoquinoline compound that is a light-sensitive competitive antagonist of GABA A receptors. It was originally identified in 1932 in plant alkaloid extracts and has been isolated from Dicentra cucullaria, Adlumia fungosa, and several Corydalis species (all in subfamily Fumarioideae, previously known as family Fumariaceae).

Since it blocks the inhibitory action of GABA receptors, the action of bicuculline mimics epilepsy; it also causes convulsions. This property is utilized in laboratories around the world in the in vitro study of epilepsy, generally in hippocampal or cortical neurons in prepared brain slices from rodents.

This compound is also routinely used to isolate glutamatergic (excitatory amino acid) receptor function. The action of bicuculline is primarily on the ionotropic GABA A receptors, which are ligand-gated ion channels concerned chiefly with the passing of chloride ions across the cell membrane, thus promoting an inhibitory influence on the target neuron.

These receptors are the major targets for benzodiazepines, z-drugs, and related anxiolytic drugs. The half-maximal inhibitory concentration (IC 50 ) of bicuculline on GABA A receptors is 2 μM +/-0.1 at 40 μM of GABA (GABA half maximal effective concentration, (EC 50 )).

In addition to being a potent GABA A receptor antagonist, bicuculline can be used to block Ca 2+ -activated potassium channels. Sensitivity to bicuculline is defined by IUPHAR as a major criterion in the definition of GABA A receptors.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1355114355 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.